Publication | Closed Access

Clinical significance of serum EGFR gene mutation and serum tumor markers in predicting tyrosine kinase inhibitor efficacy in lung adenocarcinoma

MedicineLung AdenocarcinomaPathologySerum Tumor MarkersBronchial NeoplasmCancer GenomicsPulmonary BlastomaCancer GeneticsMolecular DiagnosticsOncologyRadiation OncologyLung CancerCancer ResearchClinical Significance